Literature DB >> 19147068

Regulatory mechanisms in graft-versus-host responses.

Matthias Edinger1, Fiona Powrie, Ronjon Chakraverty.   

Abstract

Graft-versus-host disease (GVHD) is induced by donor T cells cotransplanted with the stem cell graft. The main risk factors for the development of GVHD are the degree of HLA disparity between donor and recipient and the precursor frequency and intensity of T cell responses against major or minor histocompatibility antigens. However, allogeneic T cell responses do not occur in a static and sterile environment, but are modulated by the inflammatory milieu in lymphoid and GVHD target tissues that influences the functional characteristics of antigen presenting cells APCs. Here, we summarize our recent findings concerning the pro- and anti-inflammatory function of (APCs) in the gastrointestinal tract, the role of APCs in the induction of GVH and graft-versus-leukemia (GVL) responses, and their influence on suppressive effects mediated by regulatory T cells.

Entities:  

Mesh:

Year:  2009        PMID: 19147068     DOI: 10.1016/j.bbmt.2008.10.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  7 in total

Review 1.  Microbiome-intestine cross talk during acute graft-versus-host disease.

Authors:  Hind Rafei; Robert R Jenq
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.

Authors:  James M Coghill; Stefanie Sarantopoulos; Timothy P Moran; William J Murphy; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

Review 3.  Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.

Authors:  Reena Kumari; Senthilnathan Palaniyandi; Gerhard Carl Hildebrandt
Journal:  Dig Dis Sci       Date:  2018-12-07       Impact factor: 3.199

Review 4.  Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Authors:  Jian-Ming Li; Cynthia R Giver; Ying Lu; Mohammad S Hossain; Mojtaba Akhtari; Edmund K Waller
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

Review 5.  Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects.

Authors:  Myriam N Bouchlaka; Doug Redelman; William J Murphy
Journal:  Immunotherapy       Date:  2010-05       Impact factor: 4.196

Review 6.  The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease.

Authors:  Jarosław Biliński; Marcin Jasiński; Grzegorz W Basak
Journal:  Biomedicines       Date:  2022-04-01

Review 7.  Resolution of acute intestinal graft-versus-host disease.

Authors:  Sindhu Thiagarajan; Markus F Neurath; Kai Hildner
Journal:  Semin Immunopathol       Date:  2019-10-31       Impact factor: 9.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.